RxDoctor Payments Data

Yuji Kaku, MD

Thoracic Surgery (Cardiothoracic Vascular Surgery) · Camden, NJNPI 1518408962

Payments from drug & device makers

What this record shows

This record is dominated by grants: $52,273 of the $56,672 with a category attached, or 92.2%. Abbott accounts for 93.8% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2020 at $52,416 and has fallen 98.7% since, to $673 in 2025. Among thoracic surgery (cardiothoracic vascular surgery) clinicians in NJ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$56,672in general payments, 2019–2025

Across 46 payments — averaging $1232.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$53K
  • Medtronic$2K
  • Abiomed$1K
  • Edwards Lifesciences$614
  • Atricure, Inc.$209
  • Guard Medical Inc.$30
$712in research payments, 2019–2025

Across 5 payments — averaging $142.35 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Transmedics, Inc.$712

What the payments were for

  • Grants$52,27392%
  • Travel & lodging$1,2522%
  • Food & beverage$3,1476%

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Abbott10$53,164
Medtronic8$1,601
Abiomed18$1,056
Edwards Lifesciences7$614
Atricure, Inc.2$209
Guard Medical Inc.1$30

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$56,672 in reported general payments places this provider in the 90th percentile of 129 thoracic surgery (cardiothoracic vascular surgery) providers in New Jersey.

See all thoracic surgery (cardiothoracic vascular surgery) providers in New Jersey

Medicare billing

Part B allowed, 2024
$177,291
Medicare patients
69
Services billed
260

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other thoracic surgery (cardiothoracic vascular surgery) in Camden

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →